HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy. - Nelde A; Kowalewski DJ; Backert L; Schuster H; Werner JO; Klein R; Kohlbacher O; Kanz L; Salih HR; Rammensee HG; Stevanović S; Walz JS (Oncoimmunology, 2018)